申请人:Alkermes, Inc.
公开号:US20210155636A1
公开(公告)日:2021-05-27
The present invention provides compounds useful for the treatment of narcolepsy or cataplexy in a subject in need thereof. Related pharmaceutical compositions and methods are also provided herein.
本发明提供了用于治疗需要治疗的患者的嗜睡病或猝倒的化合物。相关的药物组合物和方法也在此提供。